학술논문

Dual BTK/SYK inhibition with CG-806 (luxeptinib) disrupts B-cell receptor and Bcl-2 signaling networks in mantle cell lymphoma.
Document Type
Article
Source
Cell Death & Disease; Mar2022, Vol. 13 Issue 3, p1-11, 11p
Subject
Language
ISSN
20414889